A previous work described similar prevalence of thrombosis recurrence between patients with SN-APS (defined as clinical manifestations of APS but testing negative for criteria aPL plus the presence of at least two non-criteria manifestations) and definite APS patients [6]. This evidence concerns the gene FASLG and autoimmune polyendocrinopathy.